BRENZAVVY
Active substance: bexagliflozin
TABLET · BEXAGLIFLOZIN 20 mg/1
United StatesActive
Marketing holder: TheracosBio, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BEXAGLIFLOZIN · 20 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-da89-7526-bde7-b0f029e7b5b3,01a1208e-6808-7f5b-9fd7-ff1f0f248312,01a1208f-2ecc-7c12-a617-2be14bb28f1f;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 82381-2174
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 82381-2174 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 82381-2174 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 82381-2174 · Verified 2026-10-09 · open in source